$308.8M in CY2024 Part D spend68K claims · 32K beneficiaries · 329 plans surveyed
Questions a plan sponsor actually asks.
What is Leuprolide used for?
VABRINTY is indicated for the treatment of advanced prostate cancer.
Is there a generic for Leuprolide?
Yes. 8 ANDAs filed at FDA, 8 generic manufacturers currently shipping.
How much does my plan pay for Leuprolide?
Across 329 Part D plans, Leuprolide averages $1593.01/unit (NADAC). Lowest available: $220.12/unit. Highest in distribution: $6516.30/unit.
Is Leuprolide on the FDA shortage list?
No. Leuprolide is not currently on the FDA Drug Shortage Database.
7 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (11 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.